{"referenced_tweets": [{"type": "replied_to", "id": "1271072278315446274"}], "conversation_id": "1271071490025361410", "id": "1271075403059388416", "in_reply_to_user_id": "1253784705096454158", "created_at": "2020-06-11T13:42:46.000Z", "public_metrics": {"retweet_count": 0, "reply_count": 2, "like_count": 6, "quote_count": 0}, "source": "Twitter for iPad", "text": "@DrSeaPerle @ScottGottliebMD @steveusdin1 @Novavax Novavax will release their Phase 1 trial results on 130 humans in July. They are using a well established protocol of making a pre-fusion Covid spike protein through expression of recombinant insect cells and an adjuvant that enhances immune response.", "lang": "en", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "entities": {"mentions": [{"start": 0, "end": 11, "username": "DrSeaPerle", "id": "1253784705096454158"}, {"start": 12, "end": 28, "username": "ScottGottliebMD", "id": "40156330"}, {"start": 29, "end": 41, "username": "steveusdin1", "id": "371790609"}, {"start": 42, "end": 50, "username": "Novavax", "id": "2913798339"}]}, "author_id": "751196586", "reply_settings": "everyone", "possibly_sensitive": false}